Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M T Allende

Showing results (21-30 of 71) with videos related to

Pageof 8
Sort By:
The International Journal of Biological Markers|July 1, 1989
CA 15.3 behaviour in cystic breast diseaseF Vizoso, M T Allende, A Fueyo, et al.
The International Journal of Biological Markers|January 1, 1990
MCA and CA 15.3 serum levels in non-malignant diseases. Some preliminary resultsA Soriano, M T Allende, F Vizoso, et al.
The International Journal of Biological Markers|July 1, 1990
Serum SLX levels in patients with non tumoral pathologies. Our experience in 189 casesM T Allende, M C Roiz, F Vizoso, et al.
The International Journal of Biological Markers|July 1, 1991
High TAG-72 serum levels, defined by MoAb B72.3, in premenopausal women with benign breast disease, are associated with type I gross cystic diseaseF Vizoso, M T Allende, R Fernàndez, et al.
The International Journal of Biological Markers|January 1, 1991
Seric BCM-RIA levels in patients with lung pathologiesM T Allende, J Hernández, A Bianco, et al.
The International Journal of Biological Markers|January 1, 1990
Serum BCM levels in patients with non-tumoral pathologies: a value of 25 U/ml can be used as threshold for tumoral activityM T Allende, F Vizoso, A Fueyo, et al.
The International Journal of Biological Markers|January 1, 1991
Evidence of a correlation between CA15.3 and prolactin serum levels after TRH administration in women with gross cystic breast diseaseF Vizoso, M T Allende, A Fueyo, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 1, 1990
Evaluation of human breast cysts according to their biochemical and hormonal composition, and cytologic examinationF Vizoso, A Fueyo, M T Allende, et al.
The International Journal of Biological Markers|April 1, 1989
CA 72.4 serum levels in 298 patients with non-malignant diseasesE Sagredo, A Soriano, L Pombo, et al.
The International Journal of Biological Markers|October 1, 1992
Serum prolactin levels in women with gross cystic breast diseaseF Vizoso, M T Allende, J L García-Muñiz, et al.
Pageof 8

Showing results (21-30 of 71) with videos related to

Sort By:
Pageof 8
The International Journal of Biological Markers|July 1, 1989
CA 15.3 behaviour in cystic breast diseaseF Vizoso, M T Allende, A Fueyo, et al.
The International Journal of Biological Markers|January 1, 1990
MCA and CA 15.3 serum levels in non-malignant diseases. Some preliminary resultsA Soriano, M T Allende, F Vizoso, et al.
The International Journal of Biological Markers|July 1, 1990
Serum SLX levels in patients with non tumoral pathologies. Our experience in 189 casesM T Allende, M C Roiz, F Vizoso, et al.
The International Journal of Biological Markers|July 1, 1991
High TAG-72 serum levels, defined by MoAb B72.3, in premenopausal women with benign breast disease, are associated with type I gross cystic diseaseF Vizoso, M T Allende, R Fernàndez, et al.
The International Journal of Biological Markers|January 1, 1991
Seric BCM-RIA levels in patients with lung pathologiesM T Allende, J Hernández, A Bianco, et al.
The International Journal of Biological Markers|January 1, 1990
Serum BCM levels in patients with non-tumoral pathologies: a value of 25 U/ml can be used as threshold for tumoral activityM T Allende, F Vizoso, A Fueyo, et al.
The International Journal of Biological Markers|January 1, 1991
Evidence of a correlation between CA15.3 and prolactin serum levels after TRH administration in women with gross cystic breast diseaseF Vizoso, M T Allende, A Fueyo, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 1, 1990
Evaluation of human breast cysts according to their biochemical and hormonal composition, and cytologic examinationF Vizoso, A Fueyo, M T Allende, et al.
The International Journal of Biological Markers|April 1, 1989
CA 72.4 serum levels in 298 patients with non-malignant diseasesE Sagredo, A Soriano, L Pombo, et al.
The International Journal of Biological Markers|October 1, 1992
Serum prolactin levels in women with gross cystic breast diseaseF Vizoso, M T Allende, J L García-Muñiz, et al.
Pageof 8